| 000 | 01807 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516110612.0 | ||
| 264 | 0 | _c20130226 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1432-0428 | ||
| 024 | 7 |
_a10.1007/s00125-012-2685-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTreweeke, A T | |
| 245 | 0 | 0 |
_aN-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial. _h[electronic resource] |
| 260 |
_bDiabetologia _cNov 2012 |
||
| 300 |
_a2920-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Platelets _xcytology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 |
_aCell Communication _xdrug effects |
| 650 | 0 | 4 |
_aCell-Derived Microparticles _xdrug effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xadministration & dosage |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMonocytes _xcytology |
| 650 | 0 | 4 | _aPlacebos |
| 700 | 1 | _aWinterburn, T J | |
| 700 | 1 | _aMackenzie, I | |
| 700 | 1 | _aBarrett, F | |
| 700 | 1 | _aBarr, C | |
| 700 | 1 | _aRushworth, G F | |
| 700 | 1 | _aDransfield, I | |
| 700 | 1 | _aMacRury, S M | |
| 700 | 1 | _aMegson, I L | |
| 773 | 0 |
_tDiabetologia _gvol. 55 _gno. 11 _gp. 2920-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-012-2685-z _zAvailable from publisher's website |
| 999 |
_c22065258 _d22065258 |
||